文献速递主动脉疾病

加速康复方案缩短择期血管腔内动脉瘤修复术后住院时间的开发与评价

Development and Evaluation of an Enhanced Recovery Protocol to Reduce Length of Stay following Elective Endovascular Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2023-06-24

本研究通过单中心回顾性分析2012年至2019年择期肾下型腹主动脉瘤腔内修复术(EVAR)病例,识别与住院时间超过2天相关的因素,并据此制定含14个组成部分的加速康复方案(ERP)。随后回顾2018年至2021年74例择期EVAR患者(方案前37例、方案后37例),发现方案实施后平均住院时间从2.6天(标准差1.9)降至1.3天(标准差1.3),P<0.01,且30天再入院、术后并发症、急诊就诊及90天死亡率无显著差异。

要点

  • 择期EVAR后住院时间超过2天与多种围手术期因素相关,包括非商业保险、术前贫血、肾功能较差、开放股动脉入路、ICU停留等。
  • 基于半结构化访谈和贝叶斯加性回归树分析,开发了针对可修改因素的14个组成部分的加速康复方案。
  • 方案实施后平均住院时间从2.6天(标准差1.9)降至1.3天(标准差1.3),P<0.01,且30天再入院、并发症、急诊就诊及90天死亡率无显著差异。

核心结论

  • 通过基于信息的安全生产过程,可修改实践和程序因素以缩短择期EVAR后的住院时间。
  • 使用系统开发的加速康复方案后,择期EVAR后的住院时间被安全地缩短。

研究设计与样本

  • 方案开发前:单中心回顾性审查2012年1月至2019年12月的择期EVAR手术。
  • 方案开发后:后续回顾性审查2018年1月至2021年6月进行的择期EVAR,以评估方案前后的住院时间。
  • 方案开发前队列共216例患者;方案开发后审查了74例择期EVAR患者(方案前37例,方案后37例)。

主要发现

  • 住院时间超过2天的相关围手术期因素包括:非商业保险(43.6% vs. 26.5%;P = 0.01)、术前贫血(血红蛋白12.56 g/dL vs. 13.57 g/dL;P = 0.001)、肾功能较差(肌酐1.31 mg/dL vs. 1.01/dL;P = 0.004)、开放股动脉入路(74.4% vs. 26.5%;P < 0.001)、ICU停留(2.7天 vs. 0.9天;P < 0.001)、术后贫血(9.8 g/dL vs. 11.9 g/dL;P < 0.001)、术后肌酐(1.55 mg/dL vs. 0.97 mg/dL;P < 0.001)以及出院时需要使用β受体阻滞剂(45.5% vs. 25%;P = 0.003)。
  • 半结构化访谈揭示术后第1天全血细胞计数/生化检查、术后物理治疗评估、ICU入住、尿潴留、患者期望及回家交通工具不可用是延迟早期出院的可能可修改因素。
  • 方案实施后,平均住院时间从2.6天(标准差1.9)降至1.3天(标准差1.3);P < 0.01。
  • 方案使用前后,30天再入院、术后并发症、急诊就诊或90天死亡率无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elective endovascular abdominal aortic aneurysm repair (EVAR) can be performed safely with a short postoperative length of stay (LOS). We aimed to develop and assess the impact of an enhanced recovery protocol (ERP) on LOS after elective EVAR. METHODS: Pre-ERP development single center retrospective review of elective EVAR procedures from January 2012 to December 2019. ERP was developed by targeting factors associated with prolonged LOS (>2 days) elucidated from semistructured interviews and Bayesian additive regression tree analysis. Post-ERP development, a subsequent retrospective review of elective EVAR performed from January 2018 to June 2021 was performed to evaluate LOS before and after ERP. Primary outcome was LOS. RESULTS: Two hundred sixteen patients underwent elective infrarenal EVAR from 2012 to 2019. Periprocedural factors identified as associated with LOS >2 days included noncommercial insurance (43.6% vs. 26.5%; P = 0.01), preoperative anemia (hemoglobin 12.56 g/dL vs. 13.57 g/dL; P = 0.001), worse renal function (creatinine 1.31 mg/dL vs. 1.01/dL; P = 0.004), open femoral access (74.4% vs. 26.5%; P < 0.001), intensive care unit (ICU) stay (2.7 days vs. 0.9 days; P < 0.001), postoperative anemia (9.8 g/dL vs. 11.9 g/dL; P < 0.001), postoperative creatinine (1.55 mg/dL vs. 0.97 mg/dL; P < 0.001), and beta blocker need on discharge (45.5% vs. 25%; P = 0.003) as significant between patients with short and prolonged LOS groups. Semistructured interviews revealed postoperative day 1 complete blood count/chemistry, postoperative physical therapy evaluation, ICU admission, urinary retention, patient expectations, and unavailability of transportation home as modifiable factors that delayed early discharge. A 14-component ERP was created to target the factors identified from combined qualitative and quantitative results. Post-ERP development, 74 elective EVAR patients were reviewed from 2018 to 2021 (37 pre-ERP and 37 post-ERP). Following ERP development, the mean LOS was reduced from 2.6 (standard deviation: 1.9) to 1.3 days (standard deviation: 1.3); P < 0.01. There were no significant differences in 30-day readmission, postoperative complications, emergency room visits, or 90-day mortality before and after the ERP was used. CONCLUSIONS: Practice and procedural factors can be modified through an informed and safe process to reduce LOS after elective EVAR. LOS following elective EVAR was safely reduced following the use of a systematically developed ERP.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Polovneff AO, Olowofela AS, Rossi PJ, et al. Development and Evaluation of an Enhanced Recovery Protocol to Reduce Length of Stay following Elective Endovascular Aneurysm Repair. Ann Vasc Surg. 2023. PMID: 37356651. doi:10.1016/j.avsg.2023.05.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。